Lighthouse Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
7,860
+4,850
+161% +$829K 0.8% 26
2025
Q4
$508K Hold
3,010
0.33% 39
2025
Q3
$435K Hold
3,010
0.29% 49
2025
Q2
$381K Sell
3,010
-200
-6% -$24.6K 0.29% 50
2025
Q1
$411K Hold
3,210
0.35% 43
2024
Q4
$424K Buy
+3,210
New +$451K 0.34% 45

Other funds holding IBB

Lighthouse Financial's IBB Position: Q1 2026 in Review

Lighthouse Financial increased its iShares Biotechnology ETF (IBB) stake by 161% in Q1 2026, buying an estimated $829K and bringing the position to 7,860 shares worth $1.33M. The position accounts for 0.8% of the portfolio, ranked #26.

Lighthouse Financial first reported a position in IBB in Q4 2024 and has held it in 6 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Lighthouse Financial held 7,860 shares of iShares Biotechnology ETF worth $1.33M as of Q1 2026.
  • Lighthouse Financial bought 4,850 iShares Biotechnology ETF shares in Q1 2026, an estimated $829K.
  • iShares Biotechnology ETF made up 0.8% of Lighthouse Financial's portfolio in Q1 2026, its #26 holding.
  • Lighthouse Financial first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Lighthouse Financial's 13F filing for Q1 2026, filed 14 May 2026.